Cite

HARVARD Citation

    Cho, D. et al. (2022). Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework. Therapeutic advances in medical oncology. p. . [Online]. 
  
Back to record